Warm Water

Countries

Name	Description
Australia	Committed to the development and production of high quality aquatic vaccines for cold and warm water species in Australia.
Singapore	was built from scratch and started to operate in January 2000. The centre's main goal is to perform R&D to produce high quality Aquatic Animal Health products and application strategies for the Asia-Pacific region.
United States	In the year 1999 a decision was made to enter the Aquatic Animal Health market in the USA following the lead of Intervet International. The first product licensed was CHORULON® (hCG). The second product licensed was a live attenuated vaccine for the prevention of Enteric Septicemia of Catfish (ESC) caused by Edwardsiella ictaluri.